Francesco Gaudio | Stem Cell Research | Best Researcher Award

Posted on by Cell Biologist

Prof. Francesco Gaudio | Stem Cell Research | Best Researcher Award

Prof. Francesco Gaudio, LUM UNIVERSITY, Italy

Prof. Francesco Gaudio is a highly accomplished hematologist with over 20 years of clinical and academic expertise, specializing in lymphoproliferative neoplasms and hematopoietic stem cell transplantation. Currently serving as Assistant Professor in Hematology at University LUM Giuseppe Degennaro and a practicing medical doctor at “F. Miulli” Hospital, he has previously held long-term roles at renowned Italian hospitals. With a prolific research record, he has authored over 50 publications in high-impact journals and contributed more than 100 abstracts to international conferences. He has conducted research in leading global institutions, including Memorial Sloan-Kettering and Imperial College. Alongside clinical innovation, he is a passionate educator and experienced healthcare manager. His focus on therapeutic advances and multidisciplinary care makes him a leader in hematology research and oncology care.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Extensive Clinical and Academic Experience
    Over 20 years of dedicated work in hematology, with expertise in lymphoproliferative disorders and hematopoietic stem cell transplantation.

  2. Robust Research Profile

    • More than 50 peer-reviewed publications in Impact Factor journals.

    • 100+ abstracts presented internationally.

    • Principal and co-investigator in multinational clinical studies.

  3. Global Exposure & Collaborations
    Research training and collaborations at globally recognized centers:

    • Memorial Sloan-Kettering (USA)

    • Imperial College (UK)

    • Lyon Sud (France)

    • VHIO Barcelona (Spain)

  4. Commitment to Academic Growth

    • Teaches Blood Diseases, Oncology, and Pathology.

    • Holds National Scientific Qualification for Associate Professor level.

  5. Leadership & Management Training

    • Managerial courses from SDA Bocconi, ISTUD Foundation, and CURSUS.

  6. Multidisciplinary Impact
    Engages in translational research that bridges hematology, oncology, and emerging areas like cannabinoid therapies and survivorship in cancer.

⚠️ Areas for Improvement:

  1. Leadership in High-Impact Authorship
    While his contribution as co-author is commendable, increasing first or senior authorship in landmark studies would strengthen his research leadership visibility.

  2. Grant Leadership and Funding Acknowledgment
    No mention of competitive grant acquisition or principal leadership in major funded research networks; pursuing this could enhance academic competitiveness.

  3. Public Engagement and Open Science
    Could further boost impact by increasing participation in open-access platforms, public talks, and wider media dissemination of research findings.

🎓 Education:

Prof. Gaudio holds a Degree in Medicine and Surgery from the University of Bari (1995–1996), where he explored clonogenic hematopoietic activity in lymphoma patients. He specialized in Hematology (2001–2002), focusing on stem cell mobilization challenges. He further expanded his scientific foundation with a Postgraduate Specialization in Chemico-Pharmaceutical Research from CARSO (1998). Recognized for academic excellence, he earned the National Scientific Qualification (ASN) for Associate Professor in Hematology, Oncology, and Rheumatology in 2020. His academic path is complemented by top-tier executive and managerial training, including healthcare leadership programs from SDA Bocconi, ISTUD Foundation, and CURSUS. Early education includes a Classical High School Diploma from Liceo Classico ‘Quinto Ennio’, Taranto. His diverse education underscores a balanced mastery of clinical medicine, research, and institutional leadership.

💼 Professional Experience:

Prof. Gaudio’s medical journey spans over two decades in hematology and oncology. Since April 2024, he serves as an Assistant Professor at University LUM Giuseppe Degennaro and practices medicine at “F. Miulli” Regional Hospital. Prior to this, he was a senior hematologist at Policlinico Consorziale, AOU Bari for nearly 19 years, providing expert care and engaging in impactful research. He also worked at Ospedali Riuniti in Foggia, honing his clinical foundations. His experience includes leadership in clinical trials, management of complex hematologic malignancies, and therapeutic protocol development. He is a sought-after speaker, educator, and research collaborator with exposure to international institutions including Sloan-Kettering (USA), Imperial College (UK), and VHIO (Spain). His long-standing service and global outreach reflect deep dedication to patient care, academic excellence, and translational medicine.

🔬 Research Focus:

Prof. Gaudio’s research focuses on lymphomas, leukemias, and hematopoietic stem cell transplantation, combining clinical acumen with molecular innovation. As Principal Investigator in numerous global trials, he has helped shape advanced therapeutic strategies and enhance survival in hematological malignancies. His work delves into mobilization of CD34+ stem cells, radiotherapy-induced toxicity, and biological markers of malignancy. Recent systematic reviews explore epithelial–mesenchymal transcription factors, BPDCN, and the neurological impact of cannabidiol. His interests also span survivorship in Hodgkin lymphoma patients, with emphasis on long-term toxicity and risk evaluation. His teaching integrates updated scientific evidence into medical curricula, training the next generation of hematologists. International collaborations and cross-border research highlight his commitment to innovation and best practices in oncology. Prof. Gaudio’s work not only advances hematology but also bridges clinical gaps through interdisciplinary solutions.

📚 Publications Top Notes:

📄 Exploring the Role of Epithelial–Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review 🔬🧬

📄 Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity 🎗️📊

📄 Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34+ cells in patients with relapsed-refractory diffuse large B-cell lymphomas 🩸💉

📄 The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review 🌿🧠

📄 Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview 🔎🧫

📝 Conclusion:

Prof. Francesco Gaudio is a highly qualified and deserving candidate for the Best Researcher Award. His two decades of contribution to hematology and oncology, combined with a prolific publication record, international collaboration, and dedication to clinical innovation, clearly demonstrate excellence in medical research. While opportunities exist for expanded authorship leadership and grant visibility, his current achievements are deeply impactful and relevant to modern hematologic science. His work bridges bench-to-bedside approaches and continues to benefit both the scientific community and patient outcomes.

ALICIA MARIA TAMAYO CARBON | Stem Cell Research | Women Researcher Award

Posted on by Cell Biologist

Dr. ALICIA MARIA TAMAYO CARBON | Stem Cell Research | Women Researcher Award

Dr. ALICIA MARIA TAMAYO CARBON , HOSPITAL CLÍNICO QUIRÚRGICO HERMANOS AMEIJEIRAS , Cuba

Dra. C. Alicia María Tamayo Carbón is a highly accomplished specialist in plastic surgery and caumatology at the Hermanos Ameijeiras Clinical and Surgical Hospital in Cuba. With extensive academic and professional qualifications, she holds a medical degree, multiple specializations in comprehensive general medicine, plastic surgery, and caumatology, and is an expert in regenerative therapy. She is a researcher, professor, and author of numerous scientific papers and book chapters. Dra. Tamayo Carbón is recognized for her pioneering work in regenerative therapy using adipose tissue. She has received national recognition with awards like the National Impact Award from ANIR and the Meritorious Researcher Award from CIGB. Dra. Tamayo has collaborated with various institutions on groundbreaking research in regenerative medicine and gender reassignment. She is a prominent member of several professional organizations, contributing significantly to medical advancements in Cuba and beyond.

Publication Profile: 

Orcid

Strengths for the Award:

Dra. Alicia María Tamayo Carbón is an outstanding candidate for the Women Researcher Award due to her extensive contributions to the fields of plastic surgery, caumatology, and regenerative therapy. Her pioneering work in adipose tissue-based regenerative therapy has had a profound impact on the medical community, both nationally and internationally. With 11 ongoing research projects, 125 published journals, and significant collaborations with renowned institutions, her academic and clinical achievements have earned her multiple accolades such as the National Impact Award and Meritorious Researcher Award. Additionally, her leadership roles in scientific councils and her involvement in various groundbreaking projects highlight her influence and dedication to advancing medical practices, particularly in cosmetic and reconstructive surgery, as well as in gender reassignment. Her contributions have also led to the publication of books, patents, and a strong academic presence.

Areas for Improvement:

While Dra. Tamayo’s work is extensive and impactful, expanding her visibility in international collaborations outside of Cuba and increasing her citation index could enhance her global recognition. Further engagement in multidisciplinary collaborations, particularly in the areas of advanced technologies like AI or machine learning in surgery, could be explored to push the boundaries of her work in regenerative therapy.

Education:

Dra. Alicia María Tamayo Carbón’s academic journey reflects her dedication to advancing medical knowledge and practice. She began with a medical degree, followed by first-degree specialization in comprehensive general medicine. Her pursuit of excellence continued as she achieved both first- and second-degree specialization in plastic surgery and caumatology. Additionally, she holds a diploma in healthcare management and a university postgraduate degree in aesthetic medicine from the University of the Atlantic, Barcelona, Spain. Her academic foundation is complemented by a specialization in regenerative therapy, reinforcing her commitment to innovative treatments in her field. Dra. Tamayo Carbón’s academic achievements are paired with a passion for teaching, as she serves as a professor for the Master’s program in Aesthetic Medicine in Barcelona. Her educational path has laid the groundwork for her contributions to regenerative therapy and aesthetic medicine, making her a recognized expert in her field.

Experience:

Dra. Alicia María Tamayo Carbón boasts a rich professional background in plastic surgery and regenerative therapy. As a full professor and researcher, she has significantly contributed to the field of regenerative therapy, particularly in the use of adipose tissue for medical treatments. Her extensive experience is underscored by her clinical work at the Hermanos Ameijeiras Clinical and Surgical Hospital in Cuba. Dra. Tamayo has also held pivotal roles in national and international collaborations, including projects with the Cuban Institute of Hematology and Immunology and CEADEN, focusing on stem cell research and tissue engineering. She has been a key figure in developing regenerative therapy applications for skin disorders, gender reassignment, and reconstructive surgery. Her leadership as the head of the national specialty group and her board membership in the Cuban Society of Plastic Surgery and Caumatology further highlight her influence. Dra. Tamayo’s professional career is marked by continuous advancements in surgical and therapeutic techniques.

Research Focus:

Dra. Alicia María Tamayo Carbón’s research focus lies at the intersection of plastic surgery, regenerative medicine, and tissue engineering. Her groundbreaking work in regenerative therapy, particularly the use of adipose tissue and stem cells for medical treatments, has positioned her as a leader in this field. She has led numerous projects that explore adipose-derived stem cells, nanofat, and tissue engineering, particularly in reconstructive surgery, cosmetic procedures, and gender reassignment. Dra. Tamayo has collaborated with several national and international institutions to explore the phenotypic characterization of stem cells and their application in regenerative therapies. Her work also includes investigating new methods in tissue engineering, such as 3D bioprinting of biodegradable scaffolds for regenerative purposes. She has actively contributed to the development of clinical trials targeting stem cells from umbilical cord adipose tissue. Through her research, Dra. Tamayo Carbón aims to improve patient outcomes and advance the field of regenerative therapy in aesthetic and reconstructive surgery.

Publications Top Notes:

  1. “Utilidad del tejido adiposo en el tratamiento de las deformidades mentonianas. Un rescate de la lipotransferencia” 🦷💉
  2. “Identificación y caracterización de células madre hematopoyéticas en tejido adiposo obtenidas por nanograsa” 🧬🔬
  3. “Masculinización torácica aplicada al tratamiento de la ginecomastia grave” 💪🏽👨‍⚕️
  4. “Restauración volumétrica autóloga en pacientes con hemiatrofia adiposa facial” 🤲🏽💉
  5. “Mastoplastia de aumento, complemento indispensable de feminización en trastornos de identidad de género” 🌸🏥
  6. “Aplicación del protocolo de recuperación posquirúrgica mejorada en la liposucción abdominal” 💪🏼🛏️
  7. “Nanofat, su expansión en la asistencia médica” 🧴⚙️
  8. “Reconstrucción mamaria con colgajo dérmico en cirugía de lesión benigna con alto riesgo de malignidad” 💕🏥
  9. “Activation of the Immune System by Irresponsible use of Modeling Substances” 🦠⚠️
  10. “Tratamiento quirúrgico periorbitario, un enfoque desde la cirugía plástica” 👁️💉

Conclusion:

Dra. C. Alicia María Tamayo Carbón is an exemplary figure in the medical field, particularly in regenerative medicine and plastic surgery. Her groundbreaking research and continuous efforts to improve patient outcomes through innovative therapies make her a deserving candidate for the Research for Women Researcher Award. Her contributions have not only advanced scientific knowledge but also positively impacted clinical practices, demonstrating her exceptional commitment to both research and education. Dra. Tamayo’s expertise, leadership, and sustained contributions solidify her as a leader and an inspiration for future generations of female researchers.

 

 

 

Ying Ren | Stem Cell Research | Best Researcher Award

Posted on by Cell Biologist

Mrs. Ying Ren | Stem Cell Research | Best Researcher Award

Mrs. Ying Ren , Xuzhou Medical University , China

Ying Ren, a 32-year-old researcher from Xuzhou, Jiangsu province, China, is an accomplished scholar specializing in biomedical engineering. After completing her PhD at Peking Union Medical College, Tsinghua University Health Science Center (2015-2021), she is currently serving as a lecturer at the School of Stomatology, Xuzhou Medical University. Ren’s research journey is centered on bone marrow stem cells and their differentiation into odontogenic and osteogenic lineages. She is also deeply involved in exploring the synthesis and design of natural bioactive hydrogels aimed at enhancing bone tissue regeneration. Throughout her career, Ren has contributed to numerous impactful publications, demonstrating her expertise in the development of materials and techniques that support regenerative medicine.

Publication Profile: 

Scopus

Strengths for the Award:

Ying Ren’s academic and research profile positions her as a leading candidate for the Best Researcher Award in the field of biomedical engineering and tissue regeneration. Her research is highly innovative, with a focus on bone marrow stem cell differentiation and bioactive hydrogels designed to promote bone tissue regeneration. Ren’s ability to integrate molecular biology with material science is a key strength that is reflected in her numerous impactful publications. Her work in hydrogel design and stem cell culture systems stands out as cutting-edge, with clear implications for regenerative medicine and tissue engineering. The significant impact of her research is shown by her consistent publication in top-tier journals such as ACS Applied Bio Materials, Journal of Biomedical Nanotechnology, and Biomaterials. Moreover, her academic leadership as a lecturer at Xuzhou Medical University further demonstrates her capacity to contribute to both the scientific community and the education of future researchers.

Areas for Improvement:

While Ren’s research is highly promising, there is potential for expanding her focus to explore the clinical applications and translational aspects of her work more thoroughly. Moving beyond the lab and advancing her bioactive hydrogels and stem cell differentiation strategies toward clinical trials could greatly enhance the practical impact of her research. Additionally, while Ren has been successful in her publications, future collaborations with interdisciplinary researchers in the fields of clinical medicine and industry could help further elevate her work to new applications in regenerative therapies.

Education:

Ying Ren’s academic journey began with her Bachelor’s degree in Pharmacy from Tianjin Medical University (2011-2015), where she laid the foundation for her deep interest in biomedical sciences. She went on to pursue her PhD in Biomedical Engineering at Peking Union Medical College, Tsinghua University Health Science Center (2015-2021). Here, she focused on stem cell biology, particularly the odontogenic and osteogenic differentiation of bone marrow stem cells. Ren’s advanced research training equipped her with a solid understanding of the molecular mechanisms involved in tissue regeneration and the bioengineering of materials to promote this process. Her education has allowed her to merge the fields of pharmacy, biomedical engineering, and material science, which has been pivotal in shaping her current research direction. She has since become a well-respected academic, contributing valuable knowledge to the field of tissue engineering and regenerative medicine.

Experience:

Since August 2021, Ying Ren has been serving as a lecturer at the School of Stomatology, Xuzhou Medical University, where she continues to advance her research and teach the next generation of biomedical engineers. Before her current position, Ren had extensive academic exposure during her PhD, where she collaborated on various multidisciplinary projects that bridged the fields of stem cell biology, bioengineering, and material science. In her role as a lecturer, she not only teaches but also leads cutting-edge research in the development of natural bioactive hydrogels and their application in bone tissue regeneration. Her work is highly regarded in the academic community, and she has published several influential papers in top-tier journals. Ren’s research continues to focus on improving therapeutic outcomes for regenerative medicine, particularly through her exploration of bioactive materials designed for bone regeneration and cartilage repair.

Research Focus:

Ying Ren’s research is primarily focused on the differentiation of bone marrow-derived stem cells into odontogenic and osteogenic lineages, a key area for advancing bone tissue regeneration. She investigates the molecular and biomechanical mechanisms that regulate stem cell behavior and tissue formation. Her work emphasizes the design and synthesis of bioactive hydrogels, including collagen mimetic peptides and hyaluronic acid derivatives, to create environments that promote stem cell differentiation and tissue healing. In particular, Ren is dedicated to developing hydrogels with adjustable mechanical properties, facilitating controlled cell growth and tissue regeneration. Her innovative approach holds great promise for enhancing the repair of bone and cartilage defects. Moreover, Ren is exploring how different hydrogel stiffness and molecular structures influence stem cell fate, aiming to optimize these materials for clinical applications in regenerative medicine. Her research bridges fundamental biology with advanced materials science to address unmet medical needs in tissue engineering.

Publications Top Notes:

  1. Hyaluronic acid hydrogel with adjustable stiffness for mesenchymal stem cell 3D culture 🧬🦠, ACS Applied Bio Materials, 2021
  2. A gelatin-hyaluronic acid double cross-linked hydrogel for regulating the growth and dual dimensional cartilage differentiation of bone marrow mesenchymal stem cells 🧫💡, Journal of Biomedical Nanotechnology, 2021
  3. Locally delivered modified citrus pectin-a galectin-3 inhibitor shows expected anti-inflammatory and unexpected regeneration-promoting effects on repair of articular cartilage defect 🍊🦵, Biomaterials, 2022
  4. The effects of stiffness on the specificity and avidity of antibody-coated microcapsules with target cells are strongly shape dependent 🧪🔬, Colloids and Surfaces B: Biointerfaces, 2024
  5. A collagen mimetic peptide-modified hyaluronic acid hydrogel system with enzymatically mediated degradation for mesenchymal stem cell differentiation 🧬🛠, Materials Science & Engineering C, 2020

Conclusion:

Ying Ren’s innovative contributions to the fields of stem cell biology, bioengineering, and regenerative medicine make her a highly deserving candidate for the Best Researcher Award. Her work has the potential to advance medical treatments for bone and cartilage regeneration, a critical area in tissue engineering. With her proven track record, expertise, and dedication, Ren is well-positioned to continue leading groundbreaking research and making significant strides in the medical field.

Raveendra Pilli | Tissue Engineering Regeneration | Best Researcher Award

Posted on by Cell Biologist

Mr. Raveendra Pilli | Tissue Engineering Regeneration | Best Researcher Award

Mr. Raveendra Pilli , National Institute of technology-Silchar , India

Raveendra Pilli, a dedicated research scholar from Vijayawada, Andhra Pradesh, is currently pursuing a Ph.D. in Electronics and Communication Engineering at the National Institute of Technology Silchar, Assam. His research focuses on brain age prediction and early detection of neurological disorders using neuroimaging modalities. With extensive teaching experience, Raveendra has demonstrated excellence in course delivery, student mentoring, and research guidance. He has made significant contributions to his field through various high-impact publications, demonstrating a passion for integrating deep learning with brain health diagnostics. His goal is to bridge the gap between artificial intelligence and neuroscience, contributing to advancements in the early detection of neurological disorders such as Alzheimer’s and Parkinson’s diseases. His research continues to make strides in neuroimaging, deep learning, and medical diagnostics, earning recognition for its impact in both academia and healthcare.

Publication Profile:

Google Scholar

Strengths for the Award:

Raveendra Pilli has demonstrated remarkable academic and research achievements in the field of electronics and communication engineering, with a specific focus on brain age prediction and the early detection of neurological disorders through neuroimaging modalities. His extensive teaching experience at the undergraduate level and his current research in leveraging deep learning for brain health diagnostics highlight his strong commitment to both education and innovative research. He has published high-impact articles in renowned journals such as IEEE Transactions on Cognitive and Developmental Systems and Engineering Applications of Artificial Intelligence, with several more under review. His research is not only advancing the field of neuroimaging but also contributing significantly to healthcare, particularly in early diagnosis of diseases like Alzheimer’s and Parkinson’s. Raveendra’s use of deep learning to develop diagnostic biomarkers exemplifies his technical expertise and his ability to integrate complex methodologies into real-world applications.

Areas for Improvement:

While Raveendra has made substantial strides in his research, further collaboration with clinical and healthcare professionals could enhance the practical implementation of his findings. Building interdisciplinary networks with medical experts might provide valuable insights into the clinical validation and adoption of his research. Additionally, expanding the geographical and academic outreach of his research through more international collaborations and conference presentations would help strengthen his visibility and impact within the global research community.

Education:

Raveendra Pilli holds a Ph.D. in Electronics and Communication Engineering from the National Institute of Technology Silchar (2021–Present). His thesis focuses on leveraging deep learning techniques to establish the brain age gap as a diagnostic biomarker for neurological disorders. With an outstanding 9 CGPA, his academic journey has been marked by deep commitment to research and excellence. He completed his M.Tech. in Electronics and Communication Engineering from JNTU Kakinada in 2011, securing 76%. Prior to that, he earned a B.Tech. in the same discipline from JNTU Hyderabad in 2007, achieving a 65% score. Raveendra also excelled in his secondary and higher secondary education, with notable academic achievements. He qualified for the UGC NET examination as an Assistant Professor in 2019, further cementing his academic credentials and commitment to advancing education in electronics and communication engineering.

Experience:

Raveendra Pilli’s professional experience spans over a decade, with roles as a Senior Research Fellow and Junior Research Fellow at the National Institute of Technology Silchar, Assam, since 2021. He has supported faculty in delivering courses such as Digital Signal Processing and Basic Electronics, alongside mentoring undergraduate research projects. Previously, he worked as an Assistant Professor at SRK College of Engineering and Technology, Vijayawada (2012–2021), where he taught courses in Networks Theory, Digital Signal Processing, and Image Processing. He actively mentored students, guiding them toward academic success and research accomplishments. His teaching style includes innovative methods such as active learning to improve student engagement and learning outcomes. Raveendra’s combined teaching and research roles reflect his dedication to both educating the next generation of engineers and advancing the frontiers of research in his field, particularly in brain health and deep learning applications.

Research Focus:

Raveendra Pilli’s research focuses on the intersection of electronics, communication, and neuroscience, particularly in brain age prediction and the early detection of neurological disorders through neuroimaging modalities. His work leverages deep learning techniques to analyze brain structures and biomarkers, aiming to identify critical indicators for diseases like Alzheimer’s and Parkinson’s. He is dedicated to developing advanced methods for brain age estimation using multimodal neuroimaging, such as MRI and PET scans, combined with innovative machine learning models like deep learning and kernel regression networks. His research seeks to create diagnostic biomarkers that can be used in clinical settings for early detection and diagnosis. Raveendra’s contributions aim to improve the accuracy of neurological disorder detection, offering the potential to detect these conditions at earlier, more treatable stages. His expertise in neuroimaging, machine learning, and computational models positions him as a leading researcher in this emerging area.

Publications Top Notes:

  1. “Association of white matter volume with brain age classification using deep learning network and region-wise analysis” 🧠
  2. “Kernel Ridge Regression-based Randomized Network for Brain Age Classification and Estimation” 🔬
  3. “Brain Age Estimation Using Universum Learning-Based Kernel Random Vector Functional Link Regression Network” 🤖
  4. “Unveiling Alzheimer’s Disease through Brain Age Estimation Using Multi-Kernel Regression Network and MRI” 🧳
  5. “Multimodal neuroimaging based Alzheimer’s disease diagnosis using evolutionary RVFL classifier” 🧩
  6. “Investigating White Matter Abnormalities Associated with Schizophrenia Using Deep Learning Model and Voxel-Based Morphometry” 🧑‍🔬
  7. “Brain Age Estimation of Alzheimer’s and Parkinson’s Affected Individuals Using Self-Attention Based Convolutional Neural Network” 🧠
  8. “Brain Age Estimation Using Universum Learning-Based Kernel Random Vector Functional Link Regression Network” 📚

Conclusion:

Raveendra Pilli is an outstanding researcher with the potential to drive transformative change in the early detection and diagnosis of neurological disorders. His research has already made significant contributions to the application of deep learning in neuroimaging, and his future work promises to continue to push the boundaries of this emerging field. With his exceptional academic background, impressive publication record, and unwavering commitment to research, Raveendra is highly deserving of the Best Researcher Award.

 

 

 

Elham Hasanzadeh | Stem Cell Research | Best Researcher Award

Posted on by Cell Biologist

Assist. Prof. Dr. Elham Hasanzadeh | Stem Cell Research | Best Researcher Award

Assist. Prof. Dr. Elham Hasanzadeh , Mazandaran University of Medical Sciences , Iran

Dr. Elham Hasanzadeh is an Iranian Assistant Professor specializing in Tissue Engineering. She is currently serving in the Department of Tissue Engineering and Applied Cell Science at Mazandaran University of Medical Sciences (MAZUMS), Sari, Iran. Dr. Hasanzadeh holds a Ph.D. in Tissue Engineering from Tehran University of Medical Sciences (TUMS), where she earned the 1st rank in her class. Her research focuses on advancing tissue engineering techniques for regenerative medicine, particularly for neural, cardiac, and soft tissue regeneration. Throughout her academic career, Dr. Hasanzadeh has collaborated on numerous innovative projects and published extensively in prestigious scientific journals. Her work includes the development of scaffolds, stem cell therapies, and biomaterials for various tissue regeneration applications. As a member of international professional networks, she is committed to advancing regenerative medicine globally.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Outstanding Academic Achievements:
    • Dr. Hasanzadeh has demonstrated exceptional academic performance throughout her education, with first rank in both her M.Sc. and Ph.D. degrees from prestigious Iranian institutions, showing not only academic excellence but also dedication and deep expertise in her field.
    • Her Ph.D. thesis, titled “Fabrication of fibrin/polyurethane hydrogel scaffold seeded with endometrial stem cells differentiated into neural cells for spinal cord injury,” indicates significant contributions to cutting-edge research in tissue engineering and regenerative medicine.
  2. Extensive Research Output:
    • She has published numerous high-impact research papers in reputed journals such as International Journal of Biological Macromolecules, Regenerative Therapy, Life Sciences, and others, spanning multiple applications in tissue engineering (cardiac, neural, skin, spinal cord, etc.).
    • Her work addresses key challenges in regenerative medicine, such as scaffolding for cell growth, stem cell differentiation, and cell therapy for injury treatment, which is highly relevant and innovative.
  3. Recognition and Awards:
    • Talented Student recognition at the University of Tehran and Tehran University of Medical Sciences demonstrates her academic potential and research capabilities from an early stage.
    • First-place rankings in national entrance exams and the highest GPA in her Ph.D. cohort further validate her academic strength.
  4. Innovative Research Projects and Collaborations:
    • Dr. Hasanzadeh is involved in pioneering projects, such as 3D ovarian tissue engineering using 3D printing technology and the use of endometrial stem cells for sciatic nerve repair, which are highly innovative and promising in the medical field.
    • Her involvement in global collaborative projects, such as the use of MSCs in treating COVID-19 and regenerative medicine, adds to her recognition and the practical significance of her research.
  5. Professional Memberships and Certifications:
    • Being a member of renowned professional organizations such as ITERMS and USERN indicates her commitment to staying at the forefront of research and engaging in the global scientific community.
    • Her certifications in 3D cell culture, cell signaling, and scaffold fabrication further showcase her proficiency and versatility in various aspects of tissue engineering.

Areas for Improvement:

  1. Broader Research Scope:
    • While her focus on tissue engineering, particularly in soft tissue, neural tissue, and cardiovascular applications, is commendable, diversifying her research to cover other emerging areas in regenerative medicine could broaden her expertise and impact.
  2. Interdisciplinary Collaboration:
    • While she has worked on some interdisciplinary projects, further collaborations with fields like biomedical engineering, nanotechnology, or material science could offer more expansive research opportunities. These fields could complement her tissue engineering expertise, pushing the boundaries of what is possible in regenerative medicine.
  3. Public Outreach and Application of Research:
    • Although Dr. Hasanzadeh’s research is highly impactful, additional efforts in promoting and applying her findings in clinical settings or through public outreach could enhance the real-world application of her work.
  4. Expanding International Visibility:
    • While Dr. Hasanzadeh has an impressive research profile, increasing her visibility in global scientific networks and publishing in even more internationally recognized journals could amplify her recognition.

Education:

Dr. Elham Hasanzadeh earned her Ph.D. in Tissue Engineering (2015-2019) from the Department of Tissue Engineering and Applied Cell Science, Tehran University of Medical Sciences (TUMS), with a GPA of 19.35/20, achieving 1st rank in her cohort. Her doctoral research focused on “Fabrication of fibrin/polyurethane hydrogel scaffold seeded with endometrial stem cells differentiated into neural cells for spinal cord injury,” earning a perfect score of 20/20. Prior to that, she completed her M.Sc. in Biomedical Engineering, specializing in Tissue Engineering (2011-2014), at the University of Tehran, with a GPA of 19.02/20. Her M.Sc. thesis focused on “Evaluation of continuous differentiation of mesenchymal stem cells into endothelial cells under chemical stimulation and flow stress in a perfusion bioreactor.” She completed her B.Sc. in Biology at the University of Tehran, where she ranked 1st with a GPA of 17.56/20.

Experience:

Dr. Elham Hasanzadeh has a wealth of experience in the field of tissue engineering, with a focus on regenerative medicine, stem cell therapy, and scaffold development. She is an Assistant Professor at Mazandaran University of Medical Sciences (MAZUMS), where she conducts pioneering research on tissue engineering applications for soft, neural, and cardiovascular tissues. She has worked on multiple research projects, such as developing 3D-printed ovarian tissue engineering and using polyurethane-CNT/poly-L-lactic acid conduits for nerve regeneration. In addition, Dr. Hasanzadeh has contributed significantly to the understanding of stem cell-derived therapies, particularly in the context of COVID-19 treatment and spinal cord injury regeneration. Her extensive academic background and research activities have made her a key figure in the Iranian regenerative medicine community. Dr. Hasanzadeh’s international collaborations further highlight her commitment to advancing tissue engineering research globally.

Awards and Honors:

Dr. Elham Hasanzadeh has received numerous awards throughout her academic career, recognizing her excellence in research and academic achievements. She was honored as a talented student at the University of Tehran (UT) and Tehran University of Medical Sciences (TUMS) between 2007 and 2019. Dr. Hasanzadeh ranked 2nd nationwide in the Tissue Engineering Ph.D. entrance exam in Iran (2014). She was awarded 1st place for the highest GPA among all tissue engineering graduate students at TUMS (2019) and the highest GPA among all graduate students at UT (2011). Her research excellence has led to several prestigious publications in high-impact journals, and she continues to contribute to the advancement of tissue engineering in various medical fields. Dr. Hasanzadeh is also actively involved in professional organizations such as the Iranian Society for Tissue Engineering and Regenerative Medicine (ITERMS) and the Universal Scientific Education and Research Network (USERN).

Research Focus:

Dr. Elham Hasanzadeh’s research focuses on cutting-edge advancements in tissue engineering, with a particular interest in soft tissue, neural, and cardiovascular tissue regeneration. She explores the use of stem cells, biomaterials, and 3D scaffolding techniques to develop effective solutions for tissue repair and regeneration. Her innovative projects include designing tissue-engineered scaffolds for spinal cord injury, cardiac regeneration, and peripheral nerve repair. Dr. Hasanzadeh is also involved in the use of advanced technologies, such as 3D printing, electrospinning, and microfluidic systems, to fabricate complex tissue structures and promote cellular differentiation. Her work on the secretome of mesenchymal stem cells for COVID-19 treatment underscores her commitment to addressing current global health challenges. Dr. Hasanzadeh’s research has wide-reaching applications in regenerative medicine, aiming to improve the quality of life for patients with severe tissue damage or degenerative conditions.

Publications Top Notes:

  1. “Cardiac tissue regeneration by microfluidic generated cardiac cell-laden calcium alginate microgels and mesenchymal stem cell extracted exosomes on myocardial infarction model” 🫀
  2. “Applications of blood plasma derivatives for cutaneous wound healing: A mini-review of clinical studies” 🩸
  3. “Clinical trials of mesenchymal stem cells for the treatment of COVID-19” 💉
  4. “Collagen short nanofiber-embedded chondroitin sulfate–hyaluronic acid nanocomposite: A cartilage-mimicking in situ-forming hydrogel with fine-tuned properties” 💪
  5. “Preparation of bilayer tissue-engineered polyurethane/poly-L-lactic acid nerve conduits and their in vitro characterization for use in peripheral nerve regeneration” 🧠
  6. “Enhanced spinal cord regeneration by gelatin/alginate hydrogel scaffolds containing human endometrial stem cells and curcumin-loaded PLGA nanoparticles in rat” 🧑‍🔬
  7. “The role of Advanced technologies against COVID-19: Prevention, Detection, and treatments” 💻
  8. “Development of Tissue Engineering Scaffolds for Cancer Cell Cultures” 🧬
  9. “Injectable hydrogels in central nervous system: Unique and novel platforms for promoting extracellular matrix remodeling and tissue engineering” 💉
  10. “Enhanced sciatic nerve regeneration with fibrin scaffold containing human endometrial stem cells and insulin encapsulated chitosan particles: An in vivo study” 🦵

Conclusion:

Dr. Elham Hasanzadeh is highly deserving of the Best Researcher Award based on her exceptional academic background, innovative research, and contributions to the field of tissue engineering and regenerative medicine. Her work on stem cells, scaffolding, and regenerative therapies for spinal cord injury, cardiac tissue, and other injuries has the potential to significantly impact medical treatment options.

Her academic excellence, extensive research output, high-impact collaborations, and leadership in cutting-edge projects make her a prime candidate for this award. With a few enhancements in interdisciplinary approaches, broader global exposure, and clinical translation of her research, she could further solidify her position as a leading researcher in her field.

 

 

 

 

Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Posted on by Cell Biologist

Prof. Dr. Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Prof. Dr. Hatice Yesim Karasulu , Ege University, Faculty of Pharmacy, Pharmaceutical Technology , Turkey

Prof. Dr. H. Yeşim Karasulu is a distinguished academic and researcher in pharmaceutical technology, based at Ege University in Turkey. With a career spanning decades, she earned her Ph.D. in Pharmaceutical Technology from Ege University, where she became an Associate Professor in 2006 and a full Professor in 2011. Prof. Karasulu has held numerous positions, including consultant for the Ege University Center for Drug Research & Development (ARGEFAR) and member of the pharmaceutical technology commission at Turkey’s Ministry of Health from 2006 to 2024. She has contributed extensively to drug delivery systems and pharmaceutical formulations, especially focusing on colloidal drug delivery. Over the years, she has published over 50 research papers, authored five book chapters, and is the holder of two patents related to nano-drug delivery systems. Her work has advanced both academic knowledge and pharmaceutical industry practices.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Research Experience: Prof. Dr. H. Yeşim Karasulu has an exceptional track record with more than 50 publications, multiple patents, and ongoing research projects. Her innovative work in colloidal drug delivery systems, including liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS), positions her as a leading researcher in the pharmaceutical field.
  2. High Impact and Collaboration: Her research is widely cited with an H-index of 16 (WoS) and 18 (Scopus). She has collaborated with prestigious institutions such as the University of Vienna and the Aristotle University of Thessaloniki, further enhancing the global impact of her work.
  3. Patent and Industry Collaboration: Prof. Karasulu’s research has led to two patents and several patent applications, showcasing the practical and commercial value of her innovations. Additionally, her collaborative efforts with the pharmaceutical industry in developing drug delivery systems highlight her ability to bridge academia and industry, enhancing the potential for real-world applications.
  4. Ongoing Research Projects: Prof. Karasulu is involved in multiple research projects, both academic and industry-sponsored, demonstrating her continuous commitment to advancing pharmaceutical sciences. Her ongoing projects include drug delivery systems targeting specific organs and improving drug bioavailability and stability.
  5. Awards and Recognition: Prof. Karasulu’s achievements are recognized through awards such as the Ege ArGe First Prize and the Ege ArGe Innovation Award, confirming the innovative nature of her research.

Areas for Improvement:

  1. Broader International Visibility: While Prof. Karasulu has a strong track record within her field, expanding her international visibility by increasing collaborations with leading global pharmaceutical companies could further enhance the global reach and impact of her innovations.
  2. Diversity of Published Works: Though Prof. Karasulu has an impressive number of publications, exploring opportunities for publication in high-impact journals outside her primary research focus could enhance her visibility in other areas of pharmaceutical sciences.
  3. Focus on Translational Research: While there is a strong emphasis on preclinical studies and formulation development, further focus on clinical trials and commercialization of her innovations could enhance the practical application of her work, especially with regard to regulatory approval processes for new drug delivery systems.

Education:

Prof. Dr. H. Yeşim Karasulu pursued her academic studies at Ege University in Izmir, Turkey. She completed her Bachelor’s degree in Pharmacy at the Faculty of Pharmacy before obtaining a Ph.D. in Pharmaceutical Technology from the same institution. Her education continued with postdoctoral research at the University of Vienna, focusing on Pharmaceutical Technology and Biopharmaceutics under the guidance of Prof. Dr. Franz Gabor. This international research experience allowed her to expand her expertise in colloidal drug delivery systems, setting the foundation for her career as a researcher. Throughout her education, Prof. Karasulu’s work has concentrated on the development of drug delivery systems, with an emphasis on enhancing the bioavailability and targeting of drugs using innovative methods like liposomes, nano/microparticles, and microemulsions. Her academic background has enabled her to contribute significantly to both research and industry practices in pharmaceutical sciences.

Experience:

Prof. Dr. H. Yeşim Karasulu has a distinguished career in both academia and the pharmaceutical industry. She began her academic career as a faculty member at Ege University, where she progressed from an Assistant Professor to a full Professor in the Department of Pharmaceutical Technology. Additionally, she has been an active consultant at the Ege University Center for Drug Research & Development (ARGEFAR) since 2011. Prof. Karasulu also served as a member of the Pharmaceutical Technology Commission at the Turkish Ministry of Health’s Pharmaceuticals and Medical Devices Agency between 2006 and 2024, helping shape national pharmaceutical policies. Her extensive research has led to breakthroughs in nano-drug delivery systems, contributing to the development of two patents and several industry projects. She has worked on numerous national and international projects focusing on drug formulation, bioavailability enhancement, and targeting systems, particularly for cancer therapy and chronic diseases.

Research Focus:

Prof. Dr. H. Yeşim Karasulu’s research primarily focuses on the development and evaluation of advanced colloidal drug delivery systems. Her work spans liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS). These innovative systems aim to enhance the bioavailability, stability, and targeted delivery of pharmaceutical compounds. Prof. Karasulu has led several high-impact research projects funded by both national (TUBİTAK) and international bodies, such as the European Union. Her research is dedicated to improving the therapeutic efficacy of drugs, particularly in challenging areas like cancer treatment and chronic diseases. Prof. Karasulu’s work is closely aligned with real-world applications, as evidenced by her ongoing collaboration with the pharmaceutical industry to bring new drug delivery systems to market. Her goal is to create formulations that not only improve patient outcomes but also contribute to the overall advancement of pharmaceutical technology.

Publications Top Notes:

  1. “Degradation and gastrointestinal stability of nitrofurantoin in acidic and alkaline media” 📉💊
  2. “Sustained-release dosage form of nitrofurantoin: Part 1. Preparation of microcapsules and in vitro release kinetics” 💊🔬
  3. “33 factorial design-based optimization of the formulation of nitrofurantoin microcapsules” 🔬📊
  4. “In vitro-in vivo correlations of nitrofurantoin matrix tablet formulation” 💊⚖️
  5. “A New In Vitro/In Vivo Kinetic Correlation Method for Nitrofurantoin Matrix Tablet Formulations” 🧪💡
  6. “Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery” 💊💥
  7. “Different geometric shaped hydrogel theophylline tablets: Statistical approach for estimating drug release” 💊📐
  8. “Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates” 💊🔢
  9. “Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets” 🧪📊
  10. “Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida Albicans” 💊🦠
  11. “Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line” 🔬🧪
  12. “In vitro permeation of diclofenac sodium from novel microemulsion formulations through rabbit skin” 💊🐇
  13. “Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line” 🔬💉
  14. “Transdermal delivery of diclofenac sodium through rat skin from various formulations” 💊🦷
  15. “Controlled release of methotrexate from W/O microemulsion and its in vitro anti-tumor activity” 🧪💥

Conclusion:

Prof. Dr. H. Yeşim Karasulu is a highly deserving candidate for the Best Innovation Award. Her groundbreaking research in colloidal drug delivery systems has significantly contributed to advancements in pharmaceutical sciences. With numerous publications, patents, and collaborations, her work not only pushes the boundaries of scientific research but also has a profound impact on drug development. By focusing on broader international collaborations and further developing translational research strategies, Prof. Karasulu’s contributions to the pharmaceutical industry and academic community will continue to grow, solidifying her place as a leader in innovation.

 

 

Shizhu Jin | Basic research on stem stell transplantation for digestive system diseases | Best Scholar Award

Posted on by Cell Biologist

Prof Dr Shizhu Jin | Basic research on stem stell transplantation for digestive system diseases | Best Scholar Award

Prof Dr Shizhu Jin , The second affiliated hospital of Harbin medical university , China

Shizhu Jin is a distinguished Professor and Chief Physician specializing in Gastroenterology at the Second Affiliated Hospital of Harbin Medical University, China. With extensive experience in both clinical practice and academic research, he has significantly contributed to the field of digestive diseases. His notable achievements include securing 1 national invention patent, 6 utility model patents, and 1 software copyright. Shizhu Jin has published 44 articles in SCI journals with a cumulative impact factor of 209.635 and a total of 1249 citations, reflecting his profound impact on the field. He has been recognized with several accolades, including “Top Ten Teaching Experts of Harbin Medical University” and “Outstanding Medical Aid Expert of Heilongjiang Province.” His leadership extends to various editorial and review roles, highlighting his influence and dedication to advancing gastroenterology and hepatology.

Publication Profile

Scopus

Strengths for the Award

  1. Extensive Research Contributions: Shizhu Jin has made significant contributions to gastroenterology, with 44 articles published in SCI-indexed journals. His research includes high-impact studies with a cumulative impact factor of 209.635 and an H-index of 19, demonstrating both the volume and quality of his work.
  2. Innovative Patents: He holds 1 national invention patent, 6 utility model patents, and 1 software copyright, showcasing his ability to translate research into practical applications.
  3. Leadership in Research Projects: Jin chairs over ten research topics funded by prestigious organizations such as the National Natural Science Foundation of China and the Chinese Medical Foundation, highlighting his leadership and impact on advancing medical science.
  4. Editorial and Review Roles: His involvement as a reviewer and editorial board member for various journals underscores his expertise and influence in the field.
  5. Awards and Recognition: Jin’s accolades, including the “Top Ten Teaching Experts of Harbin Medical University” and “Outstanding Medical Aid Expert of Heilongjiang Province,” reflect his excellence in both research and teaching.

Areas for Improvement

  1. Citation Metrics: Although Jin has a solid citation record, additional high-impact publications could further enhance his research profile. Increasing the citation count of recent publications could bolster his standing in the field.
  2. Collaborations: Expanding collaborations with international researchers and institutions could increase the global impact of his research and open new avenues for innovative projects.
  3. Public Outreach: Greater engagement in public communication of research findings could improve awareness of his work and its significance to broader audiences.

Education 

Shizhu Jin pursued his medical education at Harbin Medical University, where he completed his undergraduate studies in Medicine. He further advanced his expertise with a doctoral degree in Gastroenterology, focusing on innovative research in digestive diseases. His postdoctoral training involved advanced studies and collaborative research, emphasizing the integration of clinical and experimental gastroenterology. Jin’s academic journey has been marked by continuous learning and contribution to the field through rigorous research, resulting in groundbreaking advancements in stem cell therapy and digestive system diseases. His educational background, combined with extensive hands-on experience, has established him as a leading expert and educator in his field, driving both clinical excellence and academic innovation.

Experience 

Professor Shizhu Jin has extensive experience as a leading physician and researcher in Gastroenterology. At the Second Affiliated Hospital of Harbin Medical University, he directs the Ward I of the Department of Gastroenterology, overseeing complex clinical cases and pioneering treatments. His career includes significant contributions to research with over 44 SCI-indexed publications and several high-impact patents. Jin has led numerous research projects funded by prestigious bodies like the National Natural Science Foundation of China and the Chinese Medical Foundation. His professional roles extend to editorial positions in prominent journals and advisory roles in various medical associations. His commitment to advancing medical knowledge and improving patient care through research and innovation underscores his substantial impact on both the clinical and academic aspects of gastroenterology.

Research Focus 

Shizhu Jin’s research primarily focuses on innovative approaches to treating digestive system diseases, including stem cell transplantation and regenerative medicine. His work explores the molecular mechanisms underlying gastrointestinal disorders, aiming to develop novel therapeutic strategies. Jin has made significant contributions to understanding the role of stem cells in treating liver cirrhosis and inflammatory bowel diseases. His research on the signaling pathways involved in disease progression has led to potential breakthroughs in personalized medicine. Jin’s studies on hypoxia-induced factors and tumor microenvironments highlight his commitment to advancing our knowledge of complex digestive diseases. His research not only aims to improve clinical outcomes but also strives to translate scientific discoveries into practical applications for better patient management.

Publications Top Notes

  • GABPA-Mediated Expression of HPN-AS1 Facilitates Cell Apoptosis and Inhibits Cell Proliferation in Hepatocellular Carcinoma by Promoting eIF4A3 Degradation 🧬📉 Turkish Journal of Gastroenterology, 2024, 35(7), pp. 577–586
  • Stimulation by exosomes from hypoxia-preconditioned hair follicle mesenchymal stem cells facilitates mitophagy by inhibiting the PI3K/AKT/mTOR signaling pathway to alleviate ulcerative colitis 🔬🧪 Theranostics, 2024, 14(11), pp. 4278–4296
  • Novel milestones for early esophageal carcinoma: From bench to bed 🏥📚 World Journal of Gastrointestinal Oncology, 2024, 16(4), pp. 1104–1118
  • Development and validation of a blood routine-based extent and severity clinical decision support tool for ulcerative colitis 🩸🔍 Scientific Reports, 2023, 13(1), 21368
  • BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway 🧫🩺 Heliyon, 2023, 9(11), e21010
  • Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia 🧪🔬 Computers in Biology and Medicine, 2023, 163, 107078
  • From Phenomenon to Essence: A Newly Involved lncRNA Kcnq1ot1 Protective Mechanism of Bone Marrow Mesenchymal Stromal Cells in Liver Cirrhosis 🧬💉 Advanced Science, 2023, 10(21), 2206758
  • A novel approach to improving colonoscopy learning efficiency through a colonoscope roaming system: randomized controlled trial 🏥📈 PeerJ Computer Science, 2023, 9, e1409
  • Construction of a TTN Mutation-Based Prognostic Model for Evaluating Immune Microenvironment, Cancer Stemness, and Outcomes of Colorectal Cancer Patients 🧬📊 Stem Cells International, 2023, 2023, 6079957
  • Hypoxia-induced factor and its role in liver fibrosis 🔬🩺 PeerJ, 2022, 10, e14299

Conclusion

Shizhu Jin is highly deserving of the Best Researcher Award due to his outstanding research contributions, leadership in high-impact projects, and significant innovations in gastroenterology. His extensive publication record, patent holdings, and prestigious awards reflect a remarkable career dedicated to advancing medical science. Addressing areas for improvement could further elevate his impact and recognition in the global research community.